Published in Tuberc Res Treat on April 16, 2014
Prevalence of Tuberculosis, Drug Susceptibility Testing, and Genotyping of Mycobacterial Isolates from Pulmonary Tuberculosis Patients in Dessie, Ethiopia. Tuberc Res Treat (2015) 0.87
Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis. BMC Pulm Med (2016) 0.81
Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia. BMC Public Health (2016) 0.79
Smear positive pulmonary tuberculosis and associated factors among homeless individuals in Dessie and Debre Birhan towns, Northeast Ethiopia. Ann Clin Microbiol Antimicrob (2016) 0.77
Directly observed treatment short-course (DOTS) for treatment of new tuberculosis cases in Somali Regional State, Eastern Ethiopia: ten years retrospective study. BMC Res Notes (2015) 0.75
Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya. BMC Infect Dis (2016) 0.75
Clinical, molecular and drug sensitivity pattern of mycobacterial isolates from extra-pulmonary tuberculosis cases in Addis Ababa, Ethiopia. BMC Infect Dis (2015) 0.75
Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia. Infect Drug Resist (2017) 0.75
Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. BMC Infect Dis (2017) 0.75
Mycobacterium tuberculosis in central Ethiopia: drug sensitivity patterns and association with genotype. New Microbes New Infect (2017) 0.75
Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia. Infect Drug Resist (2017) 0.75
Rifampicin resistance in mycobacterium tuberculosis patients using GeneXpert at Livingstone Central Hospital for the year 2015: a cross sectional explorative study. BMC Infect Dis (2017) 0.75
Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ (1969) 12.55
PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions. J Clin Microbiol (2003) 3.02
Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS One (2009) 2.51
Rates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infection. PLoS One (2011) 1.98
Sensitivity to anti-tuberculosis drugs in HIV-positive and -negative patients in Addis Ababa. Scand J Infect Dis (2001) 1.81
Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia. Ethiop Med J (2008) 1.72
M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania. BMC Microbiol (2007) 1.57
Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol (2002) 1.57
Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia. Int J Tuberc Lung Dis (2010) 1.45
Mycobacterium tuberculosis Beijing genotype, northern Malawi. Emerg Infect Dis (2005) 1.40
High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010. Emerg Infect Dis (2012) 1.38
Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia. Int J Tuberc Lung Dis (1997) 1.35
Patterns of anti-tuberculosis drug resistance among HIV-infected patients in Maputo, Mozambique, 2002-2003. Int J Tuberc Lung Dis (2005) 1.33
Anti-tuberculosis drug resistance in the West Province of Cameroon. Int J Tuberc Lung Dis (2000) 1.31
Anti-tuberculosis drug resistance among new and previously treated pulmonary tuberculosis patients in Cotonou, Benin. Int J Tuberc Lung Dis (2007) 1.27
Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. Indian J Med Res (2011) 1.18
First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Int J Tuberc Lung Dis (2012) 1.11
Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. BMC Res Notes (2012) 1.10
Surveillance of drug-resistant childhood tuberculosis in Bangui, Central African Republic. Int J Tuberc Lung Dis (2004) 1.08
Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar. Emerg Infect Dis (2003) 1.07
Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau. Tuber Lung Dis (1993) 1.03
Primary drug resistance to anti-tuberculosis drugs in major towns of Amhara region, Ethiopia. APMIS (2012) 1.03
Primary antimicrobial resistance among Mycobacterium tuberculosis isolates from HIV seropositive and HIV seronegative patients in Dar es Salaam Tanzania. BMC Res Notes (2008) 1.01
HIV infection and antituberculosis drug resistance among pulmonary tuberculosis patients in Harar Tuberculosis Centre, Ethiopia. East Afr Med J (1997) 1.00
Multidrug-resistant tuberculosis, Somalia, 2010-2011. Emerg Infect Dis (2013) 0.99
Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi. J Infect Dev Ctries (2012) 0.99
An alarming rate of drug-resistant tuberculosis at Ngwelezane Hospital in northern KwaZulu Natal, South Africa. Int J Tuberc Lung Dis (2004) 0.98
Low Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in Zambia. Tuberc Res Treat (2010) 0.98
Prevalence of antituberculosis drug resistance in Harar Tuberculosis Centre, Ethiopia. East Afr Med J (1997) 0.96
Resistance to first-line tuberculosis drugs in three cities of Nigeria. Trop Med Int Health (2011) 0.96
Relatively low primary resistance to anti-tuberculosis drugs in Bangui and Bimbo, Central African Republic. Int J Tuberc Lung Dis (2011) 0.89
Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions. Int J Tuberc Lung Dis (2013) 0.88
Drug resistance of Mycobacterium tuberculosis complex among newly diagnosed tuberculosis cases in Burkina Faso. West Afr J Med (2010) 0.84
Bacteriological studies of tuberculosis in Sidamo Regional Hospital. Ethiop Med J (1989) 0.81
Drug sensitivity patterns of Mycobacterium tuberculosis isolated in Addis Ababa. Ethiop Med J (1984) 0.78
Fifteen-year trend in treatment outcomes among patients with pulmonary smear-positive tuberculosis and its determinants in Arsi Zone, Central Ethiopia. Glob Health Action (2014) 1.03
Seroprevalence of Brucellosis and Q-Fever in Southeast Ethiopian Pastoral Livestock. J Vet Sci Med Diagn (2013) 0.88
Oral symptoms significantly higher among long-term khat (Catha edulis) users in Ethiopia. Epidemiol Health (2015) 0.81
Prevalence of and factors associated with regular khat chewing among university students in Ethiopia. Subst Abuse Rehabil (2015) 0.79
Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia. BMC Public Health (2016) 0.79
Prevalence of Disability and Associated Factors among Registered Leprosy Patients in All Africa Tb and Leprosy Rehabilitation and Training Centre (ALERT), Addis Ababa, Ethiopia. Ethiop J Health Sci (2015) 0.75
Prevalence and Incidence of Smear-Positive Pulmonary Tuberculosis in the Hetosa District of Arsi Zone, Oromia Regional State of Central Ethiopia. BMC Infect Dis (2017) 0.75
Knowledge and perception towards net care and repair practice in Ethiopia. Malar J (2017) 0.75
Predictors of maternal and newborn health service utilization across the continuum of care in Ethiopia: A multilevel analysis. PLoS One (2022) 0.75